EcoDrugPlus

Adenosine A2a Receptor A

Ensembl ID : ENSPREG00000016442
Gene Symbol: ADORA2AA
1 Cross references
189 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSPREG00000006152
Gene Symbol: ADORA2B
3 Cross references
199 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSPREG00000012070
Gene Symbol: ADORA3
3 Cross references
134 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSPREG00000020675
Gene Symbol: ADA
3 Cross references
216 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSPREG00000011141
Gene Symbol: LOC103464836
2 Cross references
139 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSPREG00000022791
Gene Symbol: LOC103467282
3 Cross references
173 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSPREG00000011125
Gene Symbol: LOC103464675
2 Cross references
139 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSPREG00000016321
Gene Symbol: ADRA1B
3 Cross references
193 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSPREG00000004327
Gene Symbol: ADRA1B
3 Cross references
191 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSPREG00000009126
Gene Symbol: ADRA1D
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSPREG00000000294
Gene Symbol: ADRA2A
3 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSPREG00000012269
Gene Symbol: ADRA2A
3 Cross references
159 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).